EEMD Domain AR Spectral Method for Mean Scatterer Spacing Estimation of Breast Tumors From Ultrasound Backscattered RF Data.
We present a novel method for estimating the mean scatterer spacing (MSS) of breast tumors using ensemble empirical mode decomposition (EEMD) domain analysis of deconvolved backscattered radio frequency (RF) data. The autoregressive (AR) spectrum from which the MSS is estimated is obtained from the intrinsic mode functions (IMFs) due to regular scatterers embedded in RF data corrupted by the diffuse scatterers. The IMFs are chosen by giving priority to the presence of an enhanced fundamental harmonic and the presence of a greater number of higher harmonics in the AR spectrum estimated from the IMFs. The AR model order is chosen by minimizing the mean absolute percentage error (MAPE) criterion. In order to ensure that the backscattered data is indeed from a source of coherent scattering, we begin by performing a non-parametric Kolmogorov-Smirnov (K-S) classification test on the backscattered RF data. Deconvolution of the backscattered RF data, which have been classified by the K-S test as sources of significant coherent scattering, is done to reduce the system effect. EEMD domain analysis is then performed on the deconvolved data. The proposed method is able to recover the harmonics associated with the regular scatterers and overcomes many problems encountered while estimating the MSS from the AR spectrum of raw RF data. Using our technique, a mean absolute percentage error (MAPE) of 5.78% is obtained while estimating the MSS from simulated data, which is lower than that of the existing techniques. Our proposed method is shown to outperform the state of the art techniques, namely, singular spectrum analysis, generalized spectrum (GS), spectral autocorrelation (SAC), and modified SAC for different simulation conditions. The MSS for in vivo normal breast tissue is found to be 0.69 ± 0.04 mm; for benign and malignant tumors it is found to be 0.73 ± 0.03 and 0.79 ± 0.04 mm, respectively. The separation between the MSS values of normal and benign tissues for our proposed method is similar to the separations obtained for the conventional methods, but the separation between the MSS values for benign and malignant tissues for our proposed method is slightly higher than that for the conventional methods. When the MSS is used to classify breast tumors into benign and malignant, for a threshold-based classifier, the increase in specificity, accuracy, and area under curve are 18%, 19%, and 22%, respectively, and that for statistical classifiers are 9%, 13%, and 19%, respectively, from that of the next best existing technique.